Senior Immunologist (II)

Organization
4D Pharma Research Limited
Job Location
Aberdeen
United Kingdom
Job Description

Applications are invited for the role of Senior Immunologist to join the research team at 4D Pharma Research Ltd in Aberdeen (UK). The successful candidate will provide scientific expertise and leadership to the proprietary MicroRx platform, investigating microbe characteristics and host responses of LPBs progressing to the clinic. This is mainly focussed on defining mechanism of action of selected LBPs in novel disease areas using appropriate preclinical models and readouts. The role will require proven expertise in a range of immunological techniques, especially in investigating immune-mediated mechanisms in preclinical models of disease, and the proven ability to translate these skills into robust and reliable data. The post-holder will have the opportunity to engage in the wider research activities of the 4D Pharma Research team, write up results in the form of reports and publications, present research outcomes at meetings, and generate intellectual property.

Requirements
  • A PhD with relevant post-doctoral or industry experience ( >3-4 years) in immunology or a related discipline
  • Solid experience in a range of in vitro and in vivo immunology techniques and proven expertise in immunological assay development
  • Experience with investigating immune-mediated mechanisms in translational disease models
  • Ideally a Home Office personal/project licence holder (or equivalent)
  • Thorough understanding of the gut microbiome and host-microbe interactions
  • Highly motivated and innovative with the ability to work independently and integrate into a multidisciplinary team of microbiologists and molecular biologists
  • Good organisational and communication skills proven by previous line management and supervision experience
About Our Organization

4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome. Live biotherapeutic products (LBPs) derived from the gut microbiome represent a new class of drugs that contain live organisms for the prevention, treatment or cure of disease. 4D Pharma is a world leader in the LBP field and currently has two clinical stage programmes (in IBS and IBD) and a strong pipeline of pre-clinical programmes in autoimmunity, inflammation, oncology and CNS disease.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.

National Institute of Environmental Health Sciences researchers have visualized the career paths of former postdocs.

A new survey from the Pew Research Center finds that half of women working in STEM have experienced gender discrimination at work.